Full Text View
Tabular View
No Study Results Posted
Related Studies
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
This study is ongoing, but not recruiting participants.
First Received: June 6, 2001   Last Updated: February 6, 2009   History of Changes
Sponsor: Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00017225
  Purpose

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill tumor cells. Combining these therapies may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of combining chemotherapy and radiation therapy with or without peripheral stem cell transplantation in treating patients who have neuroblastoma.


Condition Intervention Phase
Neuroblastoma
Biological: filgrastim
Drug: carboplatin
Drug: cisplatin
Drug: cyclophosphamide
Drug: dacarbazine
Drug: doxorubicin hydrochloride
Drug: etoposide
Drug: ifosfamide
Drug: melphalan
Drug: tretinoin
Drug: vincristine sulfate
Drug: vindesine
Procedure: autologous bone marrow transplantation
Procedure: conventional surgery
Procedure: peripheral blood stem cell transplantation
Radiation: radiation therapy
Phase II

Study Type: Interventional
Study Design: Treatment
Official Title: Neuroblastoma Study Phase II Study of Various Therapies in Patients With Neuroblastoma

Resource links provided by NLM:


Further study details as provided by National Cancer Institute (NCI):

Study Start Date: May 1997
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   up to 20 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

DISEASE CHARACTERISTICS:

  • Histologically confirmed neuroblastoma
  • Observation stratum:

    • MYCN gene not amplified
    • Infants with stage I-IVS disease OR
    • Over 1 year of age and stage I or II resectable disease
  • Standard-risk stratum:

    • MYCN gene not amplified
    • Infants with serious symptoms and stage II-IVS disease OR
    • Over 1 year of age with stage II or III unresectable disease
  • High-risk stratum:

    • Stage IV disease OR
    • Stage I-IVS MYCN gene-amplified disease

PATIENT CHARACTERISTICS:

Age:

  • 20 and under

Performance status:

  • Not specified

Life expectancy:

  • Not specified

Hematopoietic:

  • Not specified

Hepatic:

  • Not specified

Renal:

  • No kidney insufficiency

Cardiovascular:

  • No cardiac insufficiency

Other:

  • Not pregnant
  • Fertile patients must use effective contraception
  • No other serious illness

PRIOR CONCURRENT THERAPY:

Biologic therapy:

  • Not specified

Chemotherapy:

  • No prior chemotherapy within 6 months after diagnosis

Endocrine therapy:

  • Not specified

Radiotherapy:

  • Not specified

Surgery:

  • Not specified
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00017225

  Hide Study Locations
Locations
Germany
Altonaer Kinderkrankenhaus
Hamburg, Germany, 22763
Caritaskrankenhaus
Bad Mergentheim, Germany, 97980
Carl - Thiem - Klinkum Cottbus
Cottbus, Germany, D-03048
Charite - Campus Virchow Klinikum
Berlin, Germany, D-13353
Cnopfche Kinderklinik
Nuernberg, Germany, 90419
Deutsches Rotes Kreuz
Siegen, Germany, 57072
Diakone - Krankenhaus
Schwabisch Hall, Germany, 74523
Evangelische Krankenhaus Hamm
Hamm, Germany, DOH-59063
Gemeinschaftskrankenhaus
Herdecke, Germany, 58313
Helios Klinikum Berlin
Berlin, Germany, 13122
Helios Klinikum Erfurt GmbH
Erfurt, Germany, 99012
Helios Klinikum Wuppertal
Wuppertal, Germany, D-42283
Johannes Gutenberg University
Mainz, Germany, D-55131
Johanniter-Kinderklinik
St. Augustin, Germany, 53757
Kinderklinik - Universitaetsklinikum Rostock
Rostock, Germany, D-18057
Kinderklinik Kohlhof
Neunkirchen, Germany, 66539
Kinderklinik d. TU / Schwabing
Munich, Germany, 80804
Kinderklinik der Universitaet-Bonn
Bonn, Germany, DOH-53113
Kinderklinik
Munich, Germany, DOH-80337
Kinderklinik
Giessen, Germany, D-35385
Kinderkrankenhaus Josefinum
Augsburg, Germany, 86154
Kinderkrankenhaus auf der Bult
Hannover, Germany, 30173
Kinderkrankenhaus
Kassel, Germany, 34121
Praxis am Evangelischen Krankenhaus Bethanien
Iserlohn, Germany, D-58644
Klinik Konstanz
Konstanz, Germany, 78461
Klinik und Poliklinik fuer Kinderheilkunde - Universitaetsklinikum Muenster
Muenster, Germany, D-48149
Klinikum Bayreuth
Bayreuth, Germany, 95445
Klinikum Chemnitz GMBH
Chemnitz, Germany, D-09116
Klinikum Coburg
Coburg, Germany, 96450
Klinikum Kassel
Kassel, Germany, D-34125
Klinikum Krefeld GmbH
Krefeld, Germany, D-47805
Klinikum Lippe - Detmold
Detmold, Germany, 32756
Klinikum Minden
Minden, Germany, D-32423
Klinikum Oldenburg
Oldenburg, Germany, 26133
Klinikum Schwerin
Schwerin, Germany, D-19049
Klinikum der J.W. Goethe Universitaet
Frankfurt, Germany, D-60590
Krankenanstalten Gilead
Biefeld, Germany, 33617
Krankenhaus D Barmherzigen Brueder
Regensburg, Germany, 93049
Kreiskrankenhaus Gummersbach GMBH
Gummersbach, Germany, D-51643
Leopoldina - Krankenhaus
Schwienfurt, Germany, 97422
Marien Hospital
Homburg, Germany, D-66421
Martin Luther Universitaet
Halle, Germany, 06097
Medizinische Hochschule Hannover
Hannover, Germany, D-30625
Medizinische Universitaetsklinik I
Cologne, Germany, D-50924
Mutterhaus der Borromaerinnen
Trier, Germany, D-54290
Olgahospital
Stuttgart, Germany, DOH-70176
Kindershospital
Osnabruck, Germany, D-49082
Reinhard - Nieter - Krankenhaus
Wilhelmshaven, Germany, 26389
Saarbrucker Winterbergkliniken
Saarbrucken, Germany, 66119
St. Annastift Krankenhaus
Ludwigshafen, Germany, 67065
St. Barbara Krankenhaus
Halle, Germany, 06003
St. Marien Hospital
Vechta, Germany, D-49377
Stadt Klinikum - Howedestrase
Braunschweig, Germany, 38118
Stadt. KH Dresden - Neustadt
Dresden, Germany, 01229
Stadt. Kinderklinik
Karlsruhe, Germany, 76131
Stadt. Kinderklinik
Gelsenkirchen, Germany, 45892
Stadt. Klinik - Kinderklinik
Mannheim, Germany, 68167
Stadt. Kliniken
Dortmund, Germany, 44123
Stadt. Krankenhaus Kemperhof
Koblenz, Germany, 56065
Universitaets - Kinderpoliklinik
Munich, Germany, 80336
Staedtische Krankenhaus Kiel
Kiel, Germany, 23116
Staedtisches Kinderkrankenhaus
Koln - Riehl, Germany, D-50735
Staedtisches Krankenhaus Muenchen - Harlaching
Munich, Germany, D-81545
Universitaet Ulm
Ulm, Germany, D-89075
Universitaets - Kinderklinik - Luebeck
Lubeck, Germany, 23538
Universitaets - Kinderklinik Wuerzburg
Wuerzburg, Germany, D-97080
Universitaets - Kinderklinik
Jena, Germany, D-07745
Universitaets - Kinderklinik
Erlangen, Germany, D-91054
Universitaets - Kinderklinik
Leipzig, Germany, 04317
Universitaets - Kinderklinik
Marburg, Germany, 35033
Staedtische Klinikum-Kinderklinik
Rosenheim, Germany, 83022
Universitaets Klinik fuer Kinderchirurgie
Leipzig, Germany, D-04317
Universitaets-Kinderklinik Heidelberg
Heidelberg, Germany, D-69120
Universitaets-Krankenhaus Eppendorf
Hamburg, Germany, D-20246
Universitaetskinderklinik - Universitaetsklinikum Freiburg
Freiburg, Germany, 79106
Universitaetsklinik Duesseldorf
Duesseldorf, Germany, D-40225
Universitaetsklinikum Essen
Essen, Germany, D-45122
Universitatsklinikum der MA
Magdeburg, Germany, 39112
Universitaetsklinikum Tuebingen
Tuebingen, Germany, D-72076
Universitats - Kinderklinik
Greiswald, Germany, 17487
Universitatsklinik Homburg
Homburg, Germany, 66421
Universitatsklinikum Carl Gustav Carl Carus
Dresden, Germany, D-01307
Universitaetsklinikum Goettingen
Goettingen, Germany, D-37075
University Hospital Schleswig-Holstein - Kiel Campus
Kiel, Germany, D-24105
Urologische Klinik - Universitaetsklinikum Aachen
Aachen, Germany, D-52074
Vestische Kinderklinik
Datteln, Germany, 45704
Westpfalz-Klinikum GmbH
Kaiserslautern, Germany, D-67653
Zentralklinikum Augsburg
Augsburg, Germany, DOH-86156
Zentralkrankenhaus
Bremen, Germany, D-28205
Netherlands
Academisch Ziekenhuis Maastricht
Maastricht, Netherlands, 6202 AZ
Switzerland
Kinderspital Luzerne
Luzerne 16, Switzerland, CH-6000
Ospedale "la Carita", Locarno
Locarno, Switzerland, 6600
University Children's Hospital
Zurich, Switzerland, CH-8032
University Children's Hospital
Basel, Switzerland, CH-4005
Sponsors and Collaborators
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
Investigators
Study Chair: Frank Berthold, MD Children's Hospital
  More Information

Additional Information:
Publications:
Simon T, Hero B, Bongartz R, Schmidt M, Muller RP, Berthold F. Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease. Strahlenther Onkol. 2006 Jul;182(7):389-94.
Kremens B, Hero B, Esser J, Weinel P, Filger-Brillinger J, Fleischhack G, Graf N, Gruttner HP, Niemeyer C, Schulz A, Wickmann L, Berthold F. Ocular symptoms in children treated with human-mouse chimeric anti-GD2 mAb ch14.18 for neuroblastoma. Cancer Immunol Immunother. 2002 Apr;51(2):107-10. Epub 2002 Feb 01.
Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification. Cancer. 2002 Feb 1;94(3):854-61.
Simon T, Hero B, Dupuis W, Selle B, Berthold F. The incidence of hearing impairment after successful treatment of neuroblastoma. Klin Padiatr. 2002 Jul-Aug;214(4):149-52.
Spitz R, Hero B, Westermann F, Ernestus K, Schwab M, Berthold F. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Genes Chromosomes Cancer. 2002 Jul;34(3):299-305.
Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, Schwabe D, Schilling FH, Benz-Bohm G, Berthold F. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin Oncol. 2008 Mar 20;26(9):1504-10.
Simon T, Hero B, Benz-Bohm G, von Schweinitz D, Berthold F. Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial. Pediatr Blood Cancer. 2008 May;50(5):965-9.
Berthold F, Hero B, Kremens B, Handgretinger R, Henze G, Schilling FH, Schrappe M, Simon T, Spix C. Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age. Cancer Lett. 2003 Jul 18;197(1-2):11-7.
Spitz R, Hero B, Ernestus K, Berthold F. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma. Clin Cancer Res. 2003 Jan;9(1):52-8.
Spitz R, Hero B, Ernestus K, Berthold F. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma. Med Pediatr Oncol. 2003 Jul;41(1):30-5.
Spitz R, Hero B, Ernestus K, Berthold F. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma. Clin Cancer Res. 2003 Oct 15;9(13):4835-40.
von Schweinitz D, Hero B, Berthold F. The impact of surgical radicality on outcome in childhood neuroblastoma. Eur J Pediatr Surg. 2002 Dec;12(6):402-9.

Study ID Numbers: CDR0000068664, GPOH-GERMANY-NB97, EU-20102, GER-GPOH-NB97
Study First Received: June 6, 2001
Last Updated: February 6, 2009
ClinicalTrials.gov Identifier: NCT00017225     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Cancer Institute (NCI):
localized resectable neuroblastoma
regional neuroblastoma
disseminated neuroblastoma
stage 4S neuroblastoma
recurrent neuroblastoma
localized unresectable neuroblastoma

Additional relevant MeSH terms:
Melphalan
Dacarbazine
Neuroectodermal Tumors, Primitive
Molecular Mechanisms of Pharmacological Action
Immunologic Factors
Antineoplastic Agents
Physiological Effects of Drugs
Neoplasms, Nerve Tissue
Vindesine
Cyclophosphamide
Antibiotics, Antineoplastic
Neuroblastoma
Keratolytic Agents
Cisplatin
Neoplasms, Germ Cell and Embryonal
Therapeutic Uses
Dermatologic Agents
Alkylating Agents
Etoposide
Neoplasms by Histologic Type
Mitosis Modulators
Vincristine
Antimitotic Agents
Carboplatin
Immunosuppressive Agents
Doxorubicin
Pharmacologic Actions
Neuroectodermal Tumors
Neoplasms
Ifosfamide

ClinicalTrials.gov processed this record on November 27, 2009